Related content

3D-QSAR, molecular docking studies, and binding mode prediction of thiolactomycin analogs as mtFabH inhibitors

By Lu Xiaoyun   Chen Yadong   You Qidong  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 2, 2010-04 ,pp. : 240-249

Informa Healthcare

Access to resources Recommend Favorite

Crystal Structure of MabA from Mycobacterium tuberculosis, a Reductase involved in Long-chain Fatty Acid Biosynthesis

By Cohen-Gonsaud M.   Ducasse S.   Hoh F.   Zerbib D.   Labesse G.   Quemard A.  

Journal of Molecular Biology, Vol. 320, Iss. 2, 2002-07 ,pp. : 249-261

Academic Press

Access to resources Recommend Favorite

Identification of the INO1 Gene of Mycobacterium tuberculosis H37Rv Reveals a Novel Class of Inositol-1-phosphate Synthase Enzyme

By Bachhawat N.   Mande S.C.  

Journal of Molecular Biology, Vol. 291, Iss. 3, 1999-08 ,pp. : 531-536

Academic Press

Access to resources Recommend Favorite

Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents

By Jones S.M.   Urch J.E.   Brun R.   Harwood J.L.   Berry C.   Gilbert I.H.  

Bioorganic and Medicinal Chemistry, Vol. 12, Iss. 4, 2004-02 ,pp. : 683-692

Elsevier

Access to resources Recommend Favorite

Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs

By Aich Udayanath   Meledeo M.   Sampathkumar Srinivasa-Gopalan   Fu Jie   Jones Mark   Weier Christopher   Chung Sung   Tang Benjamin   Yang Ming   Hanes Justin   Yarema Kevin  

Glycoconjugate Journal, Vol. 27, Iss. 4, 2010-05 ,pp. : 445-459

Springer Publishing Company

Access to resources Recommend Favorite